BIOMAT Database Logo BIOMAT Database Logo

Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia". 2005

Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
First Department of Internal Medicine, Faculty of Medicine, Kagawa University, Ikenobe, Mikicho, Kita-gun, Kagawa, Japan. jiro@kms.ac.jp

Recently, we have experienced significant number of patients diagnosed with non-specific interstitial pneumonia (NSIP) by open lung biopsy or video-assisted thoracoscopic surgery. The purpose of this study is to compare clinical and pathological features of idiopathic NSIP and NSIP associated with underlying diseases (mainly autoimmune disorders). Forty-six patients with histologically proven NSIP were retrospectively collected. Twenty-four patients had underlying diseases (12 polymyositis/dermatomyositis, 5 systemic sclerosis, 2 rheumatoid arthritis, 2 Sjogren's syndrome, 1 ulcerative colitis, 1 primary biliary cirrhosis, and 1 multiple myeloma). Twenty-two of the 46 patients had no underlying diseases. It was very difficult to distinguish idiopathic NSIP and NSIP associated with underlying diseases, clinically and radiologically. Pathologically, Lymphocytic pneumonitis was demonstrated in both groups, and it was impossible to distinguish idiopathic NSIP and NSIP associated with underlying diseases. Since generalized symptoms were not observed in patients with idiopathic NSIP, and clinical and pathological features were identical to NSIP with several autoimmune disorders, we postulate new clinical entities of "autoimmune interstitial pneumonia" in cases without underlying diseases.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
Idiopathic non-specific interstitial pneumonia.
February 2016, Respirology (Carlton, Vic.),
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
Idiopathic nonspecific interstitial pneumonia: an unrecognized autoimmune disease?
October 2007, American journal of respiratory and critical care medicine,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
[Idiopathic pulmonary fibrosis and non-specific interstitial pneumonia].
June 2006, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
[Sleep disorders in idiopathic non-specific interstitial pneumonia].
October 2016, Presse medicale (Paris, France : 1983),
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
August 2011, The European respiratory journal,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
[Idiopathic interstitial pneumonia with autoimmune hemolytic anemia].
June 2003, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
[Non-specific interstitial pneumonia].
January 2006, Medicina clinica,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic.
August 2008, Histopathology,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
Varicella pneumonia masquerading as interstitial lung disease: Non-specific interstitial pneumonitis.
January 2021, SAGE open medical case reports,
Jiro Fujita, and Yuji Ohtsuki, and Takeo Yoshinouchi, and Ichiro Yamadori, and Shuji Bandoh, and Michiaki Tokuda, and Hiroshi Miyawaki, and Nobuhito Kishimoto, and Toshihiko Ishida
[An autopsy case of non-specific interstitial pneumonia].
July 2005, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Copied contents to your clipboard!